Literature DB >> 1505615

Paracetamol elimination in Chinese and Indians in Singapore.

H S Lee1, T Y Ti, Y K Koh, L F Prescott.   

Abstract

The 24 h urinary excretion of paracetamol and its conjugates after oral administration of about 15 mg/kg was studied in 24 Chinese and 24 Indian healthy young adult male volunteers living in Singapore. The Indians excreted a significantly lower fraction of sulphate conjugate (28.9% compared to 35.9% in the Chinese), and a correspondingly higher fraction as glucuronide conjugate (62.2% compared to 54.5% in the Chinese). There was no difference between the ethnic groups in terms of the urinary recovery of unchanged paracetamol (Indians 3.4%, Chinese 3.6%), glutathione-derived cysteine (Indians 2.3% and Chinese 2.2%) and mercapturic acid (Indians 3.6%, Chinese 3.8%) conjugates. The total fraction of administered paracetamol recovered in the urine was 84.7% and 85.7% in the Indian and the Chinese groups, respectively. Although the total glutathione derived conjugates recovered in the two ethnic groups were similar (Indians 5.9%, Chinese 6%), the values were lower than those reported previously for Caucasians in Scotland (9.3%).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505615     DOI: 10.1007/bf02280759

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Paracetamol metabolism following overdosage: application of high performance liquid chromatography.

Authors:  D Howie; P I Adriaenssens; L F Prescott
Journal:  J Pharm Pharmacol       Date:  1977-04       Impact factor: 3.765

2.  Inter-subject and ethnic differences in paracetamol metabolism.

Authors:  J A Critchley; G R Nimmo; C A Gregson; N M Woolhouse; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

Review 3.  Ethnic differences in drug metabolism.

Authors:  W Kalow
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

4.  The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man.

Authors:  J A Clements; J A Critchley; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

5.  High performance liquid chromatographic estimation of paracetamol metabolites in plasma.

Authors:  P I Adriaenssens; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

6.  Paracetamol metabolism in African villagers.

Authors:  D K Sommers; D A van Staden; J Moncrieff; H S Schoeman
Journal:  Hum Toxicol       Date:  1985-07

7.  Sources of interindividual variations in acetaminophen and antipyrine metabolism.

Authors:  R M Nash; L Stein; M B Penno; G T Passananti; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1984-10       Impact factor: 6.875

Review 8.  The treatment of acetaminophen poisoning.

Authors:  L F Prescott; J A Critchley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

9.  Environmental factors affecting paracetamol metabolism in London factory and office workers.

Authors:  J C Mucklow; H S Fraser; C J Bulpitt; C Kahn; G Mould; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

10.  Phenol sulfotransferase in humans: properties, regulation, and function.

Authors:  R M Weinshilboum
Journal:  Fed Proc       Date:  1986-07
View more
  8 in total

1.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

2.  Impaired absorption of paracetamol in vegetarians.

Authors:  L F Prescott; K Yoovathaworn; K Makarananda; R Saivises; K Sriwatanakul
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

3.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

4.  Pharmacokinetics of zidovudine phosphorylation in human immunodeficiency virus-positive thai patients and healthy volunteers.

Authors:  Y Wattanagoon; K Na Bangchang; P G Hoggard; S H Khoo; S E Gibbons; D Phiboonbhanakit; J Karbwang; D J Back
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Paracetamol metabolism in two ethnically different Spanish populations.

Authors:  A Esteban; R Calvo; M Pérez-Mateo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

6.  Heterogeneity of paracetamol metabolism in Gilbert's syndrome.

Authors:  A Esteban; M Pérez-Mateo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Jan-Mar       Impact factor: 2.441

Review 7.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

8.  Evaluation of cut-off values in acute paracetamol overdose following the United Kingdom guidelines.

Authors:  Hyun Ho Jeong; Kyungman Cha; Kyoung Ho Choi; Byung Hak So
Journal:  BMC Pharmacol Toxicol       Date:  2022-01-05       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.